Glucagon-Like Peptide-1 7-36 Amide and Peptide YY from the L-Cell of the Ileal Mucosa Are Potent Inhibitors of Vagally Induced Gastric Acid Secretion in Man

References

• Schjodager B GT, Mortensen P E., Christiansen J, Ørskov C, Holst J J. GLP-1(Glucagon like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in man. Dig Dis Sic 1989; 35: 703–8
   Google Scholar
• Wettergren A, Schjoldager B GT, Mortensen P E., Myhre J, Christiansen J, Holst J J. Truncated GLP-1(Proglucagon 78–107 amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 1993; 38: 665–73
   PubMed Web of Science ®Google Scholar
• Adrian T E., Savage A P., Sagor G R., Allen J M., Bacarese-Ham-Ilton A J., Tatemoto K, et al. Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 1985; 89: 494–9
   PubMed Web of Science ®Google Scholar
• Böttcher G, Sjölund K, Ekblad E, Håkanson R, Schwartz T W., Sundler F. Coexistence of peptide YY and glicentin immuno-reactivity in the endocrine cells of the gut. Regul Pept 1984; 8: 261–6
   PubMed Web of Science ®Google Scholar
• Böttcher G, Aluments J, Håkanson R, Sundler F. Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study. Regul Pept 1986; 13: 283–91
   PubMedGoogle Scholar
• Hoist J J. Enteroglucagon. Adv Metab Dis 1988; 11: 392–419
   Google Scholar
• Adrian T E., Ferri G L., Bacarese-Hamilton A J., Fuessl H S., Polak J M., Bloom S R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985; 89: 1070–7
   PubMed Web of Science ®Google Scholar
• Ørskov C, Hoist J J., Poulsen S S., Kirkegaard P. Pancreatic and intestinal processing of proglucagon in man. Diabetologia 1987; 30: 874–81
   PubMedGoogle Scholar
• Pappas T N., Debas H T., Goto Y, Taylor I L. Enterogastrone like effect of peptide YY is vagally mediated in the dog. J Clin Invest 1986; 77: 49–53
   PubMedGoogle Scholar
• Ørskov C, Bersani M, Johnsen A H., Højrup P, Hoist J J. Complete sequences of glucagon-like peptide-1 from human and pig small intestine. J Biol Chem 1989; 264: 12826–9
   PubMed Web of Science ®Google Scholar
• Loud F B., Hoist J J., Christiansen J, Krarup T, Schwartz T W., Rehfeld J F. Effect of glucagon on vagally induced gastric acid secretion in humans. Dig Dis Sci 1988; 33: 408–5
   Google Scholar
• Henriksen F W., Jörgensen S P., Möller S. Interaction between secretin and cholecystokinin on inhibition of gastric secretion in man. Scand J Gastroenterol 1974; 9: 735–40
   PubMed Web of Science ®Google Scholar
• Ørskov C, Jeppesen J, Madsbad S, Hoist J J. Proglucagon products in plasma in non-insulin dependent diabetics and non-diabetic controls in fasting state and following oral glucose and intravenous arginine. J Clin Invest 1990; 87: 415–23
   Web of Science ®Google Scholar
• Andersen H B., Jensen E W., Hoist J J., Christensen N J. Increments in plasma neuropeptide Y in relation to plasma noradrenaline after food intake exceeds that during physical exercise in man. Scand J Clin Lab Invest 1993, In press
   Google Scholar
• Hilsted L, Hoist J J. On the accuracy of radioimmunological determination of somatostatin in plasma. Regul Peptides 1983; 4: 13–31
   Google Scholar
• Stadil F, Refeld J F. Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol 1973; 8: 101–12
   PubMed Web of Science ®Google Scholar
• Debas H T. Peripheral regulation of gastric secretion. Physiology of the gastrointestinal tract, 2nd ed, L R. Johnson. Raven Press, New York 1987; 931–45
   Google Scholar
• Kosaka T, Lim R KS. Demonstration of the humoral agent in fat inhibition of gastric secretion. Proc Soc Exp Biol Med 1930; 27: 890–1
   Google Scholar
• Feng T P., Hou H C., Lim R KS. On the mechanism of the inhibition of gastric secretion by fat. Chin J Physiol 1929; 3: 371–80
   Google Scholar
• Guo Y S., Sinhg P, Gomez G, Greeley G H., Thompson J C. Effect of peptide YY on cephalic, gastric and intestinal phase of gastric acid secretion and on the release of gastrointestinal hormones. Gastroenterology 1987; 92: 1202–8
   PubMedGoogle Scholar
• Gou Y S., Mok L, Cooper C, Thomson J C., Shing P. Effect of peptide YY (PYY) on somatostatin and gastrin release from isolated perfused rat stomach. Endocrinology 1986; 118(Suppl)931
   Google Scholar
• Ørskov C, Hoist J J., Nielsen O V. Effect of truncated glucagon-like peptide-1 (proglucagon 78–107 amide) on endocrine secretion from pig pancreas, antrum, and stomach. Endocrinology 1988; 123: 2009–13
   PubMed Web of Science ®Google Scholar
• Eissele R, Koop H, Arnold R. Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in rat. Scand J Gastroenterol 1990; 25: 449–54
   PubMed Web of Science ®Google Scholar
• Sheikh S P. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function. Am J Physiol 1991; 261: G701–15
   Google Scholar
• Ørskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 1992, In press
   Google Scholar
• Kanse S M., Kreymann B, Ghatei M A., Bloom S R. Identification and characterization of glucagon-like peptide-1 7–36 amide-binding sites in the rat brain and lung. FEBS Lett 1988; 241: 209–12
   PubMed Web of Science ®Google Scholar
• Seifert H, Gallwitz, Schmidt W E., Creutzfeldt W. Mapping of 125I-GLP-1 (7–36)-NH2 binding sites in rat brain [abstract]. Digestion 1990; 46(Suppl 1)104
   Google Scholar
• Whitcomb D C., Taylor I L., Vigna S R. Characterization of saturable binding sites for circulating pancreatic polypeptide in rat brain. Am J Physiol 1990; 259: G687–91
   PubMedGoogle Scholar